Cargando…
Computational research of mTORC1 inhibitor on cerebral ischemia-reperfusion injury
Ischemic stroke contributes to more than 80% of all strokes and has the four characteristics of high prevalence, high disability, high mortality, and high recurrence. Stroke is a preventable and controllable disease. In addition to controlling the primary disease, effective prevention and control me...
Autores principales: | Li, Hui, Yang, Wenzhuo, Wang, Zhenhua, Wang, Xu, Hao, Yulei, Xi, Jianxin, Lu, Han, Du, Zhishan, Feng, Jiachun, Zhang, Bao, Ma, Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386574/ https://www.ncbi.nlm.nih.gov/pubmed/34343111 http://dx.doi.org/10.18632/aging.203371 |
Ejemplares similares
-
Computational research of Belnacasan and new Caspase-1 inhibitor on cerebral ischemia reperfusion injury
por: Li, Hui, et al.
Publicado: (2022) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1
por: Du, Heng, et al.
Publicado: (2023) -
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
por: Feldman, Morris E, et al.
Publicado: (2009)